AKBA icon

Akebia Therapeutics
AKBA

Overview Fund Activity

50 hedge funds and large institutions have $200M invested in Akebia Therapeutics in 2014 Q2 according to their latest regulatory filings, with 50 funds opening new positions, increasing their positions, reducing their positions, and 3 closing their positions.

Holders
50
Holders Change
+47
Holders Change %
+1,566.67%
% of All Funds
1.44%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
50
Increased
–
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
NHAS
1
Novo Holdings A/S
Denmark
$42.1M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$28.3M
3
HM
3
HealthCor Management
New York
$25M
4
RCM
4
RA Capital Management
Massachusetts
$16.6M
5
Franklin Resources
5
Franklin Resources
California
$14.2M

Top Sellers

1
GGHC
1
Gilder Gagnon Howe & Co
New York
$0
2
LCM
2
Laurion Capital Management
New York
$0
3
Citadel Advisors
3
Citadel Advisors
Florida
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
GGHC
51
Gilder Gagnon Howe & Co
New York
– -$1.22M -62,380 Closed
LCM
52
Laurion Capital Management
New York
– -$449K -22,975 Closed
Citadel Advisors
53
Citadel Advisors
Florida
– -$361K -18,448 Closed
1 2
3